Search results for "Rating scale"

showing 10 items of 537 documents

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.

2015

Background Extended-release guanfacine hydrochloride (GXR), a selective α2A-adrenergic agonist, is a nonstimulant medication for attention-deficit/hyperactivity disorder (ADHD). This phase 3, double-blind, placebo-controlled, randomised-withdrawal study evaluated the long-term maintenance of GXR efficacy in children/adolescents with ADHD. Methods Children/adolescents (6–17 years) with ADHD received open-label GXR (1–7 mg/day). After 13 weeks, responders were randomised to GXR or placebo in the 26-week, double-blind, randomised-withdrawal phase (RWP). The primary endpoint was the percentage of treatment failure (≥50% increase in ADHD Rating Scale version IV total score and ≥2-point increase …

Malemedicine.medical_specialtyAdolescentPlacebo03 medical and health sciences0302 clinical medicineDouble-Blind MethodRating scaleInternal medicineOutcome Assessment Health CareDevelopmental and Educational PsychologymedicineClinical endpointAdrenergic alpha-2 Receptor AgonistsHumansTreatment FailureGuanfacine HydrochloridePsychiatryTrial registrationChildTime to treatment failure030227 psychiatryGuanfacinePsychiatry and Mental healthAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsPediatrics Perinatology and Child HealthFemaleExtended releasePsychology030217 neurology & neurosurgeryEfficacy StudyJournal of child psychology and psychiatry, and allied disciplines
researchProduct

Randomized, double-blind, placebo controlled, multicentre study of idebenone in patients suffering from multi-infarct dementia

1992

Abstract In this randomized double-blind, placebo controlled, multicentre study on 108 elderly patients with mild to moderate mental deterioration of vascular origin, idebenone — a benzoquinone derivative with a hydroxyalkyl side chain — proved to be therapeutically effective in the treatment of multi-infarct dementia. The oral administration of idebenone 45 mg/day b.i.d. for 120 days significantly improved the scores of the following test in comparison with placebo: Mini Mental State, Randt Memory Test, Gottfries Rating Scale, Token Test, Toulouse Pieron Test, indicating improvements in memory attention and cognitivity. The drug was well tolerated and effective in patients with multi-infar…

Agingmedicine.medical_specialtyHealth (social science)Vascular diseaseCerebral infarctionbusiness.industrymedicine.diseasePlaceboClinical trialOral administrationRating scaleAnesthesiamedicinePhysical therapyIdebenoneDementiaGeriatrics and GerontologybusinessGerontologymedicine.drugArchives of Gerontology and Geriatrics
researchProduct

Primary enduring negative symptoms in schizophrenia and major depression.

1995

Abstract Primary enduring negative symptoms (PENS) were studied in 26 patients with DSM-III-R schizophrenia and in 94 patients with unipolar major depressive episodes 5 years after the index episode. PENS were assessed with the Schedule for Deficit Syndrome (SDS). Negative symptoms were also assessed with the Scale for Assessment of Negative Symptoms (SANS) and subclassified into primary and secondary according to the SDS. The frequency of PENS did not differ significantly between schizophrenics and non-schizophrenic patients. Enduring negative symptoms (regardless of whether primary or not) were more frequently observed in schizophrenia (65% according to the SDS, and 88% according to the S…

AdultMalemedicine.medical_specialtyPsychosisComorbidityAffect (psychology)Diagnosis DifferentialInternal medicinemedicineHumansIn patientPsychiatryBiological PsychiatryDepression (differential diagnoses)AgedNegative symptomPsychiatric Status Rating ScalesDepressive DisorderDepressionMiddle Agedmedicine.diseasePsychiatry and Mental healthSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyFollow-Up StudiesJournal of psychiatric research
researchProduct

Biased emotional recognition in depression: perception of emotions in music by depressed patients.

2010

Abstract Background Depression is a highly prevalent mood disorder, that impairs a person's social skills and also their quality of life. Populations affected with depression also suffer from a higher mortality rate. Depression affects person's ability to recognize emotions. We designed a novel experiment to test the hypothesis that depressed patients show a judgment bias towards negative emotions. Methods To investigate how depressed patients differ in their perception of emotions conveyed by musical examples, both healthy (n = 30) and depressed (n = 79) participants were presented with a set of 30 musical excerpts, representing one of five basic target emotions, and asked to rate each exc…

AdultMaleAdolescentmedia_common.quotation_subjectEmotion classificationEmotionsAngerJudgmentYoung AdultAlexithymiaEmotion perceptionmedicineHumansEmotional biasmedia_commonEmotional IntelligencePsychiatric Status Rating ScalesDepressive DisorderPsychological TestsEmotional intelligenceMiddle Agedmedicine.diseaseta3124SadnessPsychiatry and Mental healthClinical PsychologyMoodCase-Control Studiesta6131FemaleSelf ReportPsychologyMusicClinical psychologyJournal of affective disorders
researchProduct

Requestioning depression in patients with cancer: Contribution of somatic and affective symptoms to Beck's Depression Inventory

2007

Background: Depressive symptoms are a major complaint reported by cancer patients. Somatic and affective symptoms can contribute to depression. Patients and methods: We investigated the prevalence of somatic and affective depressive symptoms with the Beck Depression Inventory (BDI) in 213 hospitalized cancer patients prior to the start of chemotherapy. Results: Seventeen of 213 patients (8%) were screened positive for major depression; 40 (19%) had mild to moderate depressive symptoms. The corresponding figures for somatic and affective symptoms were 33.3% and 2.8% in the patients with major depression and 23.0% and 8.0% in those with mild to moderate depressive symptoms. Female patients, p…

AdultMalemedicine.medical_specialtyAdolescentComorbidityRisk AssessmentStatistics NonparametricHospitals UniversityAge DistributionQuality of lifeGermanyNeoplasmsSickness Impact ProfileSurveys and QuestionnairesInternal medicineAdaptation PsychologicalInterview PsychologicalPrevalencemedicineHumansSex DistributionPsychiatryDepression (differential diagnoses)AgedProbabilityPsychiatric Status Rating ScalesDepressive Disorderbusiness.industryCase-control studyBeck Depression InventoryCancerHematologyMiddle Agedmedicine.diseaseComorbidityChemotherapy regimenCausalityOncologyCase-Control StudiesQuality of LifeMajor depressive disorderFemalebusinessStress PsychologicalFollow-Up StudiesAnnals of Oncology
researchProduct

Reliability and validity of the Newcastle Scales in relation to ICD-9-classification

1987

The assessment of endogenous depression by means of the Newcastle Scales (1965, 1971) has been validated by their correlation with biological findings in many previous studies. However, reliability and cross validation studies are lacking for these scales. We found the reliability of the Newcastle Scales to be sufficient or at least moderate in a sample of 70 inpatients with major depression. In order to cross validate both scales, the clinical classification according to ICD-9 and the assessment of the Newcastle Scales have been performed independently in a sample of 112 inpatients with Major Depressive Disorder (RDC). The rate of agreement between clinical diagnosis and classification acc…

AdultMalePsychiatric Status Rating ScalesDepressive Disordermedicine.medical_specialtyPsychometricsPsychometricsTest validityMiddle Agedmedicine.diseaseCross-validationCorrelationPsychiatry and Mental healthRating scaleEndogenous depressionmedicineHumansMajor depressive disorderFemalePsychiatryPsychologyReliability (statistics)Clinical psychologyActa Psychiatrica Scandinavica
researchProduct

Clinical and Functional Outcome After Abdominal Wall Incisional Hernia Repair: Evaluation of Quality-of-Life Improvement and Comparison of Assessment…

2019

Background Hernias severely impact patient quality of life (QoL), and 80% of patients need surgical operation. The primary outcome of the study is to assess improvements in balance, posture and deambulation after abdominal hernia repair. Moreover, the study investigated the improvement in the postoperative QoL. Methods Patients operated at the Policlinico “Paolo Giaccone” at Palermo University Hospital between June 2015 and June 2017 were identified in a prospective database. The functional outcome measures and QoL assessment scales used were numeric rating scale for pain, performance-oriented mobility assessment (POMA) scale, Quebec back pain disability scale, center of gravity (barycenter…

AdultMalemedicine.medical_specialtyPsychometricsAbdominal Hernia030230 surgeryAbdominal wall03 medical and health sciences0302 clinical medicineQuality of lifeBack painNumeric Rating ScaleMedicineHumansIncisional HerniaHerniaPostoperative PeriodProspective StudiesProspective cohort studyHerniorrhaphyAgedPain Measurementbusiness.industryAbdominal WallQuebecAbdominal wall incisional hernia repair Qol posture barycenter deambulationRecovery of FunctionMiddle AgedSurgical Meshmedicine.diseaseHealth SurveysHernia Ventralmedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisPhysical therapyQuality of LifeSurgeryFemalemedicine.symptombusinessAbdominal surgeryWorld journal of surgery
researchProduct

Objective assessment of blinking and facial expressions in Parkinson’s disease using a vertical electro-oculogram and facial surface electromyography

2019

Objective: Hypomimia is a common and early symptom of Parkinson's disease (PD), which reduces the ability of PD patients to manifest emotions. Currently, it is visually evaluated by the neurologist during neurological examinations for PD diagnosis, as described in task 3.2 of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Since such an evaluation is semi-quantitative and affected by inter-variability, this paper aims to measure the physiological parameters related to eye blink and facial expressions extracted from a vertical electro-oculogram (VEOG) and facial surface electromyography (fsEMG) to differentiate PD patients from healthy control subjects (…

Malemedicine.medical_specialtyvertical electro-oculogramParkinson's diseasegenetic structuresPhysiologyParkinson's disease0206 medical engineeringElectro oculogramBiomedical EngineeringBiophysicsHypomimia02 engineering and technologyElectromyographyAudiologyObjective assessment03 medical and health sciences0302 clinical medicineRating scalePhysiology (medical)spontaneous eye blink rateHumansMedicineElectrodesAgedFacial expressionBlinkingmedicine.diagnostic_testElectromyographybusiness.industryParkinson DiseaseSignal Processing Computer-AssistedElectrooculographymedicine.disease020601 biomedical engineeringfacial surface emgFacial ExpressionElectrooculographyROC CurveArea Under CurveCase-Control StudiesFemalemedicine.symptombusiness030217 neurology & neurosurgeryPhysiological Measurement
researchProduct

Identification of minor affective disorders and implications for psychopharmacotherapy.

1991

Five hundred general practice patients with functional complaints were studied with the Polydiagnostic Interview (PODI) to see whether DSM-IIIR criteria were able to specify affective disorders satisfactorily. Almost one third of the patients received the diagnosis of depression not otherwise specified (NOS). When Research Diagnostic Criteria were applied to these patients more than 70% received specific diagnoses. A modification of DSM-IIIR algorithms enabled us to further specify diagnoses in subjects with depression NOS. On the 17-item Hamilton Depression Scale many of these patients reached scores of 13 or more which is severe enough to justify a therapy trial with antidepressants.

NosologyAdultMalemedicine.medical_specialtyPsychometricsAdolescentPsychometricsResearch Diagnostic CriteriaMinor (academic)Adjustment DisordersmedicineHumansMedical diagnosisPsychiatrySomatoform DisordersDepression (differential diagnoses)AgedAged 80 and overPsychiatric Status Rating ScalesDepressive DisorderPrimary Health CareMood DisordersNot Otherwise SpecifiedTherapy TrialMiddle AgedAnxiety DisordersPsychophysiologic DisordersPsychiatry and Mental healthClinical PsychologyFemalePsychologyClinical psychologyJournal of affective disorders
researchProduct

Spanish validation of the Sexual Addiction Screening Test.

2018

Background and aims Sexual addiction is a pathological behavior characterized by a combination of excessive sexual desire and impaired ability to control it. Its incidence ranges between 1.2% and 32.2%, although this number may vary depending on the screening tool used. This wide variability is largely due to the use of non-validated instruments (e.g., structural validity relying on exploratory analyses, instruments translated without an additional validation process, or instruments validated in another format). To deal with these limitations, this study tested the psychometric properties of the Spanish paper-and-pencil and online versions of the Sexual Addiction Screening Test (SAST). Met…

Sexual addictionAdultMale050103 clinical psychologyFull-length ReportPsychometricsAdolescentPsychometricsmedia_common.quotation_subjectSexual BehaviorMedicine (miscellaneous): Traitement & psychologie clinique [H13] [Sciences sociales & comportementales psychologie]psychometric properties: Treatment & clinical psychology [H13] [Social & behavioral sciences psychology]compulsive sexual behavior03 medical and health sciencesYoung Adult0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesYoung adultPathologicalmedia_commonPsychiatric Status Rating ScaleshypersexualityIncidence (epidemiology)Addiction05 social sciencesReproducibility of ResultsGeneral Medicinemedicine.disease030227 psychiatrySpanish validationBehavior AddictivePsychiatry and Mental healthClinical PsychologySexual desireSexual Addiction Screening Test (SAST)HypersexualityFemalemedicine.symptomPsychologyClinical psychology
researchProduct